About This Product
ProSupps Crash Blue Razz is categorized as an 'Other Combinations' supplement, featuring 14 ingredients aimed at various physiological processes. This product received an N+ Score of 58, earning an 'F' grade, indicating a generally low overall quality assessment. While it provides Zinc at a clinical dose of 24 mg, several other ingredients, including Vitamin B6 and Magnesium, are noted as underdosed compared to research-backed amounts. The formula includes ingredients like Phenibut HCl (300 mg) and L-Tryptophan (100 mg), commonly associated with relaxation or sleep support. Despite 100% label transparency, its ingredient adequacy and formula completeness scores are 33% and 25% respectively, suggesting a limited number of effective dosages. This product might appeal to individuals exploring multi-ingredient formulas for general wellness, though the overall efficacy is questionable due to the underdosed components.
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
- +Rich formula with 14 active ingredients
Weaknesses
- −Several ingredients below clinically effective doses
- −Missing several expected ingredients for its category
Ingredient Analysis (14 ingredients)
| Ingredient | Amount | Status |
|---|---|---|
| Calories | 5.000 {Calories} | N/A |
| Vitamin B6 | 0.600 mg | Under |
| Magnesium | 7.000 mg | Under |
| Zinc | 24.000 mg | Optimal |
| Total Carbohydrates | 2.000 Gram(s) | N/A |
| Ashwagandha Root Extract | 50.000 mg | N/A |
| L-Tryptophan | 100.000 mg | N/A |
| Phosphatidylserine | 4.000 mg | N/A |
| Alpha-Glyceryl Phosphoryl Choline | 5.000 mg | N/A |
| L-Carnitine L-Tartrate | 100.000 mg | N/A |
| Passion Flower extract | 30.000 mg | N/A |
| Valerian root extract | 50.000 mg | N/A |
| Phenibut HCl | 300.000 mg | N/A |
| Evodiamine | 20.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.